Viewing Company
Company Name:
BRIACELL THERAPEUTICS CORP.
CIK:
1610820
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2021-11-16
Last Filing Date:
2024-12-16
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2020-08-01 | 2021-07-31 | CY2019Q2I | 2021-11-16 | 0001493152-21-028949 | $ 4 | View |
| 2021-08-01 | 2022-01-31 | CY2021Q4I | 2022-03-15 | 0001493152-22-006886 | $ 12,864,281 | View |
| 2022-02-01 | 2022-04-30 | CY2022Q1 | 2022-06-13 | 0001493152-22-016599 | $ 15,358,947 | View |
| 2021-08-01 | 2022-07-31 | CY2021 | 2022-10-28 | 0001493152-22-029742 | $ 15,494,091 | View |
| 2022-08-01 | 2022-10-31 | CY2021Q3 | 2022-12-14 | 0001493152-22-035452 | $ 5,403,151 | View |
| 2022-11-01 | 2023-01-31 | CY2021Q4 | 2023-03-16 | 0001493152-23-007796 | $ 15,518,018 | View |
| 2022-02-01 | 2022-04-30 | CY2022Q1 | 2023-06-14 | 0001493152-23-021287 | $ 5,589,945 | View |
| 2022-08-01 | 2023-07-31 | CY2023 | 2023-10-25 | 0001493152-23-038298 | $ 2,790,400 | View |
| 2023-08-01 | 2023-10-31 | CY2023Q3 | 2023-12-14 | 0001493152-23-044892 | $ 0 | View |
| 2023-08-01 | 2023-12-20 | CY2023Q4 | 2024-03-18 | 0001493152-24-010354 | $ 175,000 | View |
| 2023-02-01 | 2023-04-30 | CY2023Q1 | 2024-06-14 | 0001493152-24-023867 | $ 2,491 | View |
| 2023-06-01 | 2024-07-31 | CY2024 | 2024-10-29 | 0001493152-24-042743 | $ 456,801 | View |
| 2024-08-01 | 2024-10-31 | CY2024Q3 | 2024-12-16 | 0001493152-24-050214 | $ 60,000 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| us-gaap | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. | View |
| us-gaap | Deferred Tax Assets, Other Loss Carryforwards | Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other. | View |
| us-gaap | Equity Method Investments | This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. | View |
| us-gaap | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Research and Development Expense | The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. | View |
| us-gaap | Number of Operating Segments | Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. | View |
| us-gaap | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture | Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). | View |
| us-gaap | Additional Paid in Capital | Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. | View |
| us-gaap | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited | Number of shares (or other type of equity) forfeited during the period. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Net of Valuation Allowance | Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| ifrs-full | 163592 | None | View |
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| dei | Entity Public Float | The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. | View |
| us-gaap | Accounts Payable and Other Accrued Liabilities, Current | Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer. | View |
| us-gaap | Accounts Payable, Trade, Current | Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. | View |
| us-gaap | Accrued Professional Fees, Current | Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Deferred Tax Liabilities, Gross | Amount of deferred tax liability attributable to taxable temporary differences. | View |
| us-gaap | Deferred Offering Costs | Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. | View |
| us-gaap | Deferred Tax Assets, Gross | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature. | View |
| us-gaap | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. | View |
| us-gaap | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. | View |
| us-gaap | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. | View |
| us-gaap | Assets | Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Current | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Fair Value Disclosure | Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Noncurrent | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. | View |
| us-gaap | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Class of Warrant or Right, Exercise Price of Warrants or Rights | Exercise price per share or per unit of warrants or rights outstanding. | View |
| us-gaap | Common Stock, No Par Value | Face amount per share of no-par value common stock. | View |
| us-gaap | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | View |
| us-gaap | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | View |
| us-gaap | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | View |
| us-gaap | Deferred Tax Assets, Property, Plant and Equipment | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment. | View |
| us-gaap | Deferred Tax Assets, Tax Deferred Expense | Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances. | View |
| us-gaap | Deferred Tax Assets, Valuation Allowance | Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs | Amount of deferred tax liability attributable to taxable temporary differences from debt issuance costs. | View |
| us-gaap | Deferred Tax Liabilities, Property, Plant and Equipment | Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment. | View |
| us-gaap | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. | View |
| us-gaap | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | View |
| us-gaap | Extinguishment of Debt, Amount | Gross amount of debt extinguished. | View |
| us-gaap | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. | View |
| us-gaap | Finite-Lived Intangible Assets, Accumulated Amortization | Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, Year One | Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, Year Five | Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, Year Four | Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, Year Three | Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, Year Two | Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Finite-Lived Intangible Assets, Gross | Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. | View |
| us-gaap | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. | View |
| us-gaap | Finite-Lived Patents, Gross | Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights. | View |
| us-gaap | Foreign Currency Transaction Gain (Loss), before Tax | Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. | View |
| us-gaap | Gain (Loss) on Extinguishment of Debt | Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. | View |
| us-gaap | Number of Reporting Units | Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment. | View |
| us-gaap | Impairment of Intangible Assets, Finite-lived | The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. | View |
| us-gaap | Impairment of Long-Lived Assets Held-for-use | The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Domestic | The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Foreign | The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile. | View |
| us-gaap | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings. | View |
| us-gaap | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. | View |
| us-gaap | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. | View |
| us-gaap | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid. | View |
| us-gaap | Increase (Decrease) in Prepaid Expense | The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. | View |
| us-gaap | Interest and Debt Expense | Interest and debt related expenses associated with nonoperating financing activities of the entity. | View |
| us-gaap | Interest Expense | Amount of the cost of borrowed funds accounted for as interest expense. | View |
| us-gaap | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. | View |
| us-gaap | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. | View |
| us-gaap | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. | View |
| us-gaap | Financial and Nonfinancial Liabilities, Fair Value Disclosure | Fair value of financial and nonfinancial obligations. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | View |
| us-gaap | Net Income (Loss) Available to Common Stockholders, Basic | Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. | View |
| us-gaap | Long-Lived Assets | Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets. | View |
| us-gaap | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). | View |
| us-gaap | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. | View |
| us-gaap | Operating Loss Carryforwards | Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. | View |
| us-gaap | Other Accrued Liabilities, Current | Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. | View |
| us-gaap | Payments for Repurchase of Equity | The cash outflow to reacquire common and preferred stock. | View |
| us-gaap | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. | View |
| us-gaap | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Proceeds from Issuance Initial Public Offering | The cash inflow associated with the amount received from entity's first offering of stock to the public. | View |
| us-gaap | Proceeds from Issuance of Private Placement | The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. | View |
| us-gaap | Proceeds from Issuance of Unsecured Debt | The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt. | View |
| us-gaap | Proceeds from Issuance of Warrants | The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). | View |
| us-gaap | Proceeds from (Repurchase of) Equity | The net cash inflow or outflow resulting from the entity's share transaction. | View |
| us-gaap | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. | View |
| us-gaap | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. | View |
| us-gaap | Repayments of Short-term Debt | The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. | View |
| us-gaap | Repayments of Unsecured Debt | The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt. | View |
| us-gaap | Retained Earnings (Accumulated Deficit) | The cumulative amount of the reporting entity's undistributed earnings or deficit. | View |
| us-gaap | Share-based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price | Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | The risk-free interest rate assumption that is used in valuing an option on its own shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price | Change in the weighted average exercise price of options outstanding. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | Weighted average price at which option holders acquired shares when converting their stock options into shares. | View |
| us-gaap | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. | View |
| us-gaap | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. | View |
| us-gaap | Share Price | Price of a single share of a number of saleable stocks of a company. | View |
| us-gaap | Stockholders' Equity Attributable to Parent | Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. | View |
| us-gaap | Stock Issued | The fair value of stock issued in noncash financing activities. | View |
| us-gaap | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. | View |
| us-gaap | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. | View |
| us-gaap | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. | View |
| us-gaap | Stock Repurchased During Period, Value | Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. | View |
| us-gaap | Unrecognized Tax Benefits | Amount of unrecognized tax benefits. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | View |
| us-gaap | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. | View |
| us-gaap | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. | View |
| us-gaap | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. | View |
| us-gaap | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | View |
| us-gaap | Class of Warrant or Right, Outstanding | Number of warrants or rights outstanding. | View |
| us-gaap | Amortization | The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. | View |
| us-gaap | Deferred Tax Assets, in Process Research and Development | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | Percentage of domestic federal statutory tax rate applicable to pretax income (loss). | View |
| us-gaap | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. | View |
| us-gaap | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. | View |
| us-gaap | Share-based Payment Arrangement, Expense | Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. | View |
| us-gaap | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. | View |
| us-gaap | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method. | View |
| us-gaap | Stockholders' Equity Attributable to Noncontrolling Interest | Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest). | View |
| us-gaap | Net Income (Loss) Attributable to Noncontrolling Interest | Amount of Net Income (Loss) attributable to noncontrolling interest. | View |
| us-gaap | Net Income (Loss) Available to Common Stockholders, Diluted | Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. | View |
| us-gaap | Preferred Stock Dividends and Other Adjustments | The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders. | View |
| us-gaap | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. | View |
| us-gaap | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. | View |
| us-gaap | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Other | Amount of other increase (decrease) in additional paid in capital (APIC). | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | 163740 | None | View |
| us-gaap | Income (Loss) from Equity Method Investments | Amount of income (loss) for proportionate share of equity method investee's income (loss). | View |
| us-gaap | Payments to Acquire Other Investments | Amount of cash outflow to acquire investments classified as other. | View |
| us-gaap | Proceeds from (Repayments of) Related Party Debt | Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts. | View |
| us-gaap | Derivative Liability, Noncurrent | Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. | View |
| us-gaap | Increase (Decrease) in Accounts Payable, Trade | Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Payments to Acquire Investments | The cash outflow associated with the purchase of all investments (debt, security, other) during the period. | View |
| us-gaap | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. | View |
| us-gaap | Deferred Tax Assets, Investment in Subsidiaries | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the entity's investment in its wholly-owned subsidiaries. | View |
| us-gaap | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. | View |
| us-gaap | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. | View |
| us-gaap | Other Prepaid Expense, Current | Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. | View |
| us-gaap | Prepaid Expense, Noncurrent | Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer. | View |
| us-gaap | Property, Plant and Equipment, Additions | Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | View |
Chart of Accounts => Accounts
| Name | View |
|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | View |
| Accounts Payable and Other Accrued Liabilities, Current | View |
| Accounts Payable, Trade, Current | View |
| Accounts Receivable, after Allowance for Credit Loss, Current | View |
| Accrued Professional Fees, Current | View |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | View |
| Additional Paid in Capital, Common Stock | View |
| Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | View |
| APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | View |
| Amortization of Intangible Assets | View |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | View |
| Assets | View |
| Assets, Current | View |
| Assets, Fair Value Disclosure | View |
| Assets, Noncurrent | View |
| Cash and Cash Equivalents, at Carrying Value | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | View |
| Class of Warrant or Right, Exercise Price of Warrants or Rights | View |
| Common Stock, No Par Value | View |
| Common Stock, Par or Stated Value Per Share | View |
| Common Stock, Shares, Issued | View |
| Common Stock, Shares, Outstanding | View |
| Common Stock, Value, Issued | View |
| Deferred Tax Liabilities, Gross | View |
| Deferred Offering Costs | View |
| Deferred Tax Assets, Gross | View |
| Deferred Tax Assets, Net of Valuation Allowance | View |
| Deferred Tax Assets, Operating Loss Carryforwards | View |
| Deferred Tax Assets, Operating Loss Carryforwards, Foreign | View |
| Deferred Tax Assets, Other Loss Carryforwards | View |
| Deferred Tax Assets, Property, Plant and Equipment | View |
| Deferred Tax Assets, Tax Deferred Expense | View |
| Deferred Tax Assets, Valuation Allowance | View |
| Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs | View |
| Deferred Tax Liabilities, Property, Plant and Equipment | View |
| Depreciation, Depletion and Amortization | View |
| Earnings Per Share, Basic | View |
| Equity Method Investments | View |
| Extinguishment of Debt, Amount | View |
| Fair Value Adjustment of Warrants | View |
| Finite-Lived Intangible Assets, Accumulated Amortization | View |
| Finite-Lived Intangible Asset, Expected Amortization, after Year Five | View |
| Finite-Lived Intangible Asset, Expected Amortization, Year One | View |
| Finite-Lived Intangible Asset, Expected Amortization, Year Five | View |
| Finite-Lived Intangible Asset, Expected Amortization, Year Four | View |
| Finite-Lived Intangible Asset, Expected Amortization, Year Three | View |
| Finite-Lived Intangible Asset, Expected Amortization, Year Two | View |
| Finite-Lived Intangible Assets, Gross | View |
| Finite-Lived Intangible Assets, Net | View |
| Finite-Lived Patents, Gross | View |
| Foreign Currency Transaction Gain (Loss), before Tax | View |
| Gain (Loss) on Extinguishment of Debt | View |
| General and Administrative Expense | View |
| Impairment of Intangible Assets, Finite-lived | View |
| Impairment of Long-Lived Assets Held-for-use | View |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | View |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | View |
| Income (Loss) from Continuing Operations before Income Taxes, Foreign | View |
| Income Tax Expense (Benefit) | View |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | View |
| Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | View |
| Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Amount | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | View |
| Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount | View |
| Increase (Decrease) in Accounts Payable | View |
| Increase (Decrease) in Accounts Receivable | View |
| Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | View |
| Increase (Decrease) in Prepaid Expense | View |
| Interest and Debt Expense | View |
| Interest Expense | View |
| Investment Income, Interest | View |
| Liabilities and Equity | View |
| Liabilities, Current | View |
| Financial and Nonfinancial Liabilities, Fair Value Disclosure | View |
| Liabilities, Noncurrent | View |
| Net Cash Provided by (Used in) Financing Activities | View |
| Net Cash Provided by (Used in) Operating Activities | View |
| Net Income (Loss) Attributable to Parent | View |
| Net Income (Loss) Available to Common Stockholders, Basic | View |
| Long-Lived Assets | View |
| Nonoperating Income (Expense) | View |
| Operating Income (Loss) | View |
| Operating Loss Carryforwards | View |
| Other Accrued Liabilities, Current | View |
| Payments for Repurchase of Equity | View |
| Payments of Stock Issuance Costs | View |
| Prepaid Expense, Current | View |
| Proceeds from Issuance Initial Public Offering | View |
| Proceeds from Issuance of Private Placement | View |
| Proceeds from Issuance of Unsecured Debt | View |
| Proceeds from Issuance of Warrants | View |
| Proceeds from (Repurchase of) Equity | View |
| Proceeds from Warrant Exercises | View |
| Property, Plant and Equipment, Net | View |
| Repayments of Short-term Debt | View |
| Repayments of Unsecured Debt | View |
| Research and Development Expense | View |
| Retained Earnings (Accumulated Deficit) | View |
| Share-based Payment Arrangement, Noncash Expense | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | View |
| Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | View |
| Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | View |
| Share Price | View |
| Stockholders' Equity Attributable to Parent | View |
| Stock Issued | View |
| Stock Issued During Period, Value, Conversion of Convertible Securities | View |
| Stock Issued During Period, Value, New Issues | View |
| Stock Issued During Period, Value, Other | View |
| Stock Repurchased During Period, Value | View |
| Unrecognized Tax Benefits | View |
| Weighted Average Number of Shares Outstanding, Basic | View |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | View |
| Operating Expenses | View |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | View |
| Earnings Per Share, Diluted | View |
| Weighted Average Number of Shares Outstanding, Diluted | View |
| Class of Warrant or Right, Outstanding | View |
| Number of Operating Segments | View |
| Number of Reporting Units | View |
| Shares Issued, Shares, Share-based Payment Arrangement, Forfeited | View |
| Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture | View |
| Amortization | View |
| Deferred Tax Assets, in Process Research and Development | View |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | View |
| Proceeds from Issuance of Common Stock | View |
| Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | View |
| Additional Paid in Capital | View |
| Share-based Payment Arrangement, Expense | View |
| Depreciation, Depletion and Amortization, Nonproduction | View |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | View |
| Stockholders' Equity Attributable to Noncontrolling Interest | View |
| Net Income (Loss) Attributable to Noncontrolling Interest | View |
| Net Income (Loss) Available to Common Stockholders, Diluted | View |
| Preferred Stock Dividends and Other Adjustments | View |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | View |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | View |
| Stock Issued During Period, Shares, New Issues | View |
| Adjustments to Additional Paid in Capital, Other | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | View |
| 162270 | View |
| Income (Loss) from Equity Method Investments | View |
| Payments to Acquire Other Investments | View |
| Proceeds from (Repayments of) Related Party Debt | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | View |
| Derivative Liability, Noncurrent | View |
| Increase (Decrease) in Accounts Payable, Trade | View |
| Net Cash Provided by (Used in) Investing Activities | View |
| Payments to Acquire Investments | View |
| Stock Issued During Period, Value, Stock Options Exercised | View |
| Deferred Tax Assets, Investment in Subsidiaries | View |
| Depreciation | View |
| Intangible Assets, Net (Excluding Goodwill) | View |
| Other Prepaid Expense, Current | View |
| Payments to Acquire Property, Plant, and Equipment | View |
| Prepaid Expense, Noncurrent | View |
| Property, Plant and Equipment, Additions | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | View |